About NZOZ Lecznica MAK-MED. S.C.
"NZOZ Lecznica MAK-MED w Nadarzynie jest firmą rodzinną i istnieje od kwietnia 1995 r. Od sierpnia 2009 r. pracujemy w nowoczesnej siedzibie położonej w pobliżu nadarzyńskiego, sosnowego lasu z wygodnym, oznakowanym dojazdem oraz parkingiem tylko dla naszych Pacjentów. Nasza przychodnia jest w pełni przystosowana do przyjmowania osób niepełnosprawnych. Nasi Pacjenci są pod opieką doświadczonej, wyspecjalizowanej i przyjaznej kadry medycznej. Lekarze specjaliści uczestniczą w licznych kursach krajowych i zagranicznych stale podnosząc swoje kwalifikacje."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at NZOZ Lecznica MAK-MED. S.C.
During the past decade, NZOZ Lecznica MAK-MED. S.C. conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 21 clinical trials were completed, i.e. on
average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 13 clinical trials were completed. i.e. 65%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NZOZ Lecznica MAK-MED. S.C." #1 sponsor was "Pfizer" with 14 trials, followed by "Janssen Research & Development, LLC" with 8 trials
sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Abivax S.A." with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Lecznica MAK-MED. S.C."
#1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at NZOZ Lecznica MAK-MED. S.C.
According to Clinical.Site data, the most researched conditions in "NZOZ Lecznica MAK-MED. S.C." are
"Rheumatoid Arthritis" (12 trials), "Arthritis, Psoriatic" (7 trials), "Systemic Lupus Erythematosus" (6 trials), "Psoriatic Arthritis" (4 trials) and "Arthritis, Rheumatoid" (3 trials). Many other conditions were trialed in "NZOZ Lecznica MAK-MED. S.C." in a lesser frequency.
Clinical Trials Intervention Types at NZOZ Lecznica MAK-MED. S.C.
Most popular intervention types in "NZOZ Lecznica MAK-MED. S.C." are "Drug" (35 trials), "Other" (7 trials) and "Biological" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (22 trials), "Guselkumab" (6 trials), "Baricitinib" (4 trials), "Adalimumab" (3 trials) and "Methotrexate" (3 trials). Other intervention names were less common.
Clinical Trials Genders at NZOZ Lecznica MAK-MED. S.C.
The vast majority of trials in "NZOZ Lecznica MAK-MED. S.C." are
39 trials for "All" genders.
Clinical Trials Status at NZOZ Lecznica MAK-MED. S.C.
Currently, there are NaN active trials in "NZOZ Lecznica MAK-MED. S.C.".
undefined are not yet recruiting,
7 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 25 completed trials in NZOZ Lecznica MAK-MED. S.C.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in NZOZ Lecznica MAK-MED. S.C., 2 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 0 trials that are defined as “Not Applicable".